Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study. [electronic resource]
- Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 03 2020
- 472-479 p. digital
Publication Type: Journal Article
1523-6536
10.1016/j.bbmt.2019.10.017 doi
Adult Graft vs Host Disease Hematopoietic Stem Cell Transplantation Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy Protein Kinase Inhibitors--therapeutic use